on behalf of the RAISE study group investigators. Efficacy of immunoglobulin prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomized, open-label, blinded-endpoints trial
on behalf of the RAISE study group investigators. Efficacy of immunoglobulin prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomized, open-label, blinded-endpoints trial
复制标题
代表 RAISE 研究组研究人员。
DOI：
--
复制
发表时间：
2012
期刊：
影响因子：
--
通讯作者：
Ryuji Fukazawa
中科院分区：
文献类型：
--
作者：
Tohru Kobayashi;Tsutomu Saji;Tetsuya Otani;Kazuo Takeuchi;Tetsuya Nakamura;Hirokazu Arakawa;Taichi Kato;Toshiro Hara;Kenji Hamaoka;Shunichi Ogawa;Masaru Miura;Yuichi Nomura;Shigeto Fuse;Fukiko Ichida;Mitsuru Seki;Ryuji Fukazawa
